PUBLISHER: Allied Market Research | PRODUCT CODE: 1344280
PUBLISHER: Allied Market Research | PRODUCT CODE: 1344280
According to a new report published by Allied Market Research, titled, "Artificial Joints Market," The artificial joints market was valued at $20.2 billion in 2022, and is estimated to reach $31.8 billion by 2032, growing at a CAGR of 4.6% from 2023 to 2032.
Artificial joints, also known as prosthetic joints or joint replacement, is a medical device designed to replace damaged or diseased joints in the human body. These joints are primarily used to restore joint function and relieve pain in individuals with conditions, such as arthritis, joint degeneration, or joint injuries. Artificial joints are typically composed of a combination of metal alloys, high-density plastics, and ceramic materials. The design and composition of artificial joints vary depending on the specific joint being replaced, such as hip, knee, shoulder, or elbow.
The artificial joints market growth is driven by high presence of market players who manufacture artificial joints and increase in prevalence of orthopedic diseases. In addition, an artificial joint (called a prosthesis) is used in various types of arthritis, such as osteoarthritis, or degenerative joint disease. Thus, rise in prevalence of orthopedic diseases and increase in prevalence of osteoarthritis are anticipated to drive the growth of the market. For instance, according to Center for Disease Control and Prevention (CDC), in 2021, about 23.7% of adults were diagnosed with arthritis in the U.S. Arthritis is more common in women (23.5%) as compared to men (18.1%).
In addition, increase in prevalence of obesity, modern sedentary lifestyles, long hours of sitting, lack of physical activity, and injuries to the joints, such as sports-related injuries, repetitive stress injuries, or accidents, can increase the risk of developing osteoarthritis. Thus, this factor is anticipated to drive the demand for surgical treatment and usage of artificial joints, which fuels the growth of the market.
Geriatric population is more susceptible to osteoarthritis. Thus, increase in the number of geriatric populations is expected to witness growth in prevalence of osteoarthritis. Therefore, this is expected to increase the number of surgical interventions, increase the demand for artificial joints and boost the growth of the market. According to World Health Organization, (WHO), population aged 60 years and over were expected to increase from 1 billion in 2020 to 1.4 billion in 2022 globally. By 2050, the global population of people aged 60 years and older is expected to double . The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.
On the other hand, side effects associated with artificial joints and surgical procedures related to joint degeneration are anticipated to hamper the growth of the market. Moreover, high cost of surgical procedure and availability of substitutional option such as exercise are expected to restrain the growth of the market. For instance, side effects of surgery such as nerve or blood vessel damage, infection, blood clots, implant problems, pain and stiffness, allergic reaction and others is anticipated to hamper the growth of the market.
However, increase in demand for medical services in the developed countries such as U.S., Canada, and Germany and growth opportunities in emerging markets are expected to create immense opportunities for the artificial joints market during the forecast period.
The artificial joints market is segmented on the basis of type, application, material, end user, and region. On the basis of type, the market is bifurcated into cemented artificial joints and non-cemented artificial joints. On the basis of application, the market is divided into artificial knee joints, artificial hip joints, and others. Others includes shoulder artificial joint and ankle artificial joint. On the basis of material, the market is segmented into ceramics, alloy, and others. Others includes high-density plastics and oxinium. On the basis of end user, the market is bifurcated into hospitals and Others.
Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Major key players that operate in the global artificial joints market are: Zimmer Biomet, Smith & Nephew, Stryker Corporation, DePuy Synthes, B. Braun, Aesculap, Medtronic, Medacta International, Exactech, and MicroPort Orthopedics Inc. Key players operating in the market have adopted product approval, product launch, acquisition, and agreement as their key strategies to expand the artificial joints market share.